Adagio Medical Holdings (ADGM) Liabilities and Shareholders Equity (2023 - 2026)

Adagio Medical Holdings (ADGM) has 4 years of Liabilities and Shareholders Equity data on file, last reported at $39.3 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity fell 4.91% year-over-year to $39.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $150.0 million (down 23.86% YoY) and the FY2025 annual result came in at $43.3 million, down 10.72% from the prior year.
• Liabilities and Shareholders Equity retreated to $39.3 million in Q1 2026 per ADGM's latest filing, from $43.3 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $107.2 million in Q3 2024 and bottomed at $6.8 million in Q4 2023.
• The 4-year median for Liabilities and Shareholders Equity is $40.3 million (2025), against an average of $44.2 million.
• The widest annual swing landed in 2024, when Liabilities and Shareholders Equity soared 609.86%; it then tumbled 70.57% in 2025.
• Tracing ADGM's Liabilities and Shareholders Equity over 4 years: stood at $6.8 million in 2023, then soared by 609.86% to $48.4 million in 2024, then dropped by 10.72% to $43.3 million in 2025, then decreased by 9.12% to $39.3 million in 2026.
• Per Business Quant, the three latest ADGM Liabilities and Shareholders Equity figures stand at $39.3 million (Q1 2026), $43.3 million (Q4 2025), and $31.5 million (Q3 2025).

Peer Comparison